Introduction
Natural killer (NK) cells are important components of the innate immune system (1-3). Unlike T and B cells, NK cells efficiently exert their effector functions, classically without the necessity of prior sensitization, and mainly through direct cytotoxicity and the production of various cytokines, thus providing the first line of defense against pathogens and tumors. NK cells are thought to develop primarily in the bone marrow (BM) during adult life (4, 5) , and NK cell maturation is a multistep process associated with progressive acquisition and/or downregulation of a series of markers (6) . NK cell precursors (NKPs), expressing CD122 and lacking NK cell-specific markers, are traditionally defined as comprising the first stage of NK lineage commitment and can give rise to immature NK cells after acquisition of NK 1.1 in C57BL/6 (B6) mice (7) . Immature NK cells further differentiate into mature NK cells, involving the sequential expression of DX5 (CD49b), CD11b, KLRG1, and CD27 (6, (8) (9) (10) . Although mature NK cells represent the main NK cell population in the peripheral organs, there is accumulating evidence that phenotypically immature NK cells are not unique to the BM, suggesting that NK cell development may also take place at peripheral sites (11) (12) (13) or that these cells may represent distinct NK cell subsets.
As innate immune effectors, NK cells have long been considered to lack immunological memory, a hallmark of adaptive immune cells. NK cells do not express recombination-activating gene (RAG) proteins, which are necessary for recombination events that are required to generate a large repertoire of diverse antigen-specific receptors in T and B cells (14, 15) . Strikingly, however, recent findings demonstrated that NK cells can mount a robust recall response following specific activation by chemical haptens (16) (17) (18) or viruses (17, 19, 20) , or nonspecific activation by cytokines (21) , respectively. Among the NK cells examined for apparent "antigen-specific" responses, hepatic but not splenic NK cells confer hapten-or virus-specific responses, whereas conventional splenic NK cells can mediate memory-like effects following murine cytomegalovirus (MCMV) and cytokine stimulation (19, 21) . Particularly, in contact hypersensitivity (CHS) and non-MCMV studies, hapten-and virus-specific "memory" liver NK cells express Ly49C/I (16), CXCR6 (17) , and/or Thy1 (20) . However, these molecules are expressed on other cells, including splenic NK cells (1, 15) . Therefore, liver NK cells endowed with memory-like properties do not have a phenotype that can distinguish them from other NK cells.
On the other hand, previous studies have suggested that liver NK cells may be phenotypically distinct from conventional splenic NK cells, which in turn resemble NK cells in peripheral blood. For example, the liver contains an unusually high proportion (up to 50%) of phenotypically immature NK cells, expressing TNF-related apoptosis-inducing ligand (TRAIL) and lacking DX5 (6, 11, 22) , whereas NK cells at other peripheral sites are predominantly mature in phenotype and function. Notably, during early life, the phenotypically immature NK cells are predominant in the liver and can also be found in the spleen (11) . In contrast to the sharp decline of these NK cells in the spleen after birth, in the liver they only mildly decrease with age and maintain a stable subpopulation in adult mice (11) . Finally, these liver NK cells have relatively low proliferative capacity in the steady state (22) . Thus, these studies suggest that there may be an organ-specific, i.e., liver-specific, NK cell population endowed with memory-like properties and distinguishable from conventional NK cells in the spleen and peripheral circulation, perhaps akin to thymic NK cells (13) .
Challenges to identifying such a putative liver-specific NK cell subpopulation relate to several unique aspects of the liver, including two afferent vascular supplies and distinctive immunological features. Through the portal vein that drains the abdominal organs including the spleen, the liver receives about 75% of its afferent blood, exposing the liver to a variety of antigens and microbial products from the gastrointestinal tract. This nutrient-rich blood mixes with oxygenated blood from the hepatic artery in the sinusoids, a highly fenestrated, low-pressure vascular system containing many innate immune cells, especially NK cells. Interestingly, NK cells are difficult to identify on liver tissue sections, consistent with their residence in the sinusoids rather than in the liver parenchyma per se (23) . Thus, if the liver contains a liver-resident NK cell population, the cells should reside in the sinusoids where they are mixed with circulating NK cells, which may be phenotypically distinguishable.
Herein, we precisely describe the fundamental features of liver-resident NK cells. We characterized their unique phenotype as CD49a + DX5 -, and found that they are involved in the immunological memory response in NK cell-mediated CHS models and that their hematopoietic progenitor cells (HPCs) and precursors exist in the liver. Thus, our experiments suggest that liver-resident NK cells confer memory-like responses in CHS.
Results

Hepatic DX5 -NK cells confer CHS responses.
Since hepatic NK cells, but not splenic NK cells, can elicit hapten-specific CHS responses (16, 17) , we hypothesized that the phenomenon was due to a distinct NK cell subset present in the liver and not in the spleen. One clue to this subset was the description of DX5 -NK cells enriched in the liver that were speculated to be an immature population similar to one identified in the BM (6) . Here, we examined the expression of DX5 and NK1.1 on CD122 + CD3 -CD19 -cells from different organs in B6 mice (Figure 1,  A and B) . Consistent with previous findings, DX5 -NK1.1 -cells resembling NKPs were detectable in the BM, liver, spleen, and lymph nodes (12) . The DX5 + NK1.1 + subset, defined as conventional NK cells, was abundant in all examined organs. Surprisingly, however, nearly half of hepatic NK1.1 + NK cells were DX5 -, whereas approximately 5%-8% of NK1.1 + NK cells in other organs were DX5 -.
To test the potential role of the DX5 -subset in CHS, we sensitized Rag1 -/-or WT mice with oxazolone (OXA) then adoptively transferred their DX5 -or DX5 + liver NK cells into naive WT recipients. One month later, recipients were challenged with OXA and ear swelling was measured. Only recipients that received sensitized hepatic DX5 -NK cells displayed marked ear inflammation, whereas recipients of sensitized hepatic DX5 + NK cells or sensitized splenic NK cells were unresponsive ( Figure 1, C and D) . Thus, the immunological memory capacity of liver NK cells in CHS models can be attributed to hepatic DX5 -NK cells, suggesting that hepatic DX5 -NK cells are functionally distinct from hepatic DX5 + and splenic NK cells, potentially as a unique subset.
"Memory" NK cells remain DX5 -during hapten priming in the liver. To verify whether the sensitized "memory" NK cells are naive hepatic DX5 -NK cells, but not differentiated from other NK cell subsets including both non-liver NK cells and DX5 + NK cells, we transferred naive hepatic DX5 -or DX5 + NK cells sorted from GFP transgenic mice into lethally irradiated recipients followed by sensitization with OXA at days 1 and 2. The liver mononuclear cells (MNCs) from the lethally irradiated recipients were isolated at day 5 (before irradiation-induced death), and adoptively transferred by intravenous injection into secondary naive recipients, which was followed by challenge 1 month later (Figure 2A) . Before secondary transfer, donor GFP + DX5 -NK cells in irradiated recipients remained DX5 -following sensitization with OXA, and donor GFP + DX5 + NK cells consistently maintained expression of DX5 ( Figure 2B ), indicating that hapten sensitization did not affect DX5 expression on NK cells. Importantly, we found that only secondary recipients that received liver MNCs from the first sensitized recipients, which in turn had received naive hepatic DX5 -NK cells, could mount hapten-specific CHS responses ( Figure 2C ). These results demonstrate that only naive hepatic DX5 -NK cells, not other NK cell subsets, have memory potential.
Taken together with the rarity of naive DX5 -NK cells in peripheral tissues except the liver, these findings raise the possibility that the liver may be a site where naive NK cells are primed, in which case haptens would need to be delivered to the liver to elicit
Figure 2
Hepatic NK cells with memory capacity remain DX5 -during hapten sensitization. (A) DX5 -or DX5 + NK (NK1.1 + CD3 -CD19 -) cells (10 5 ) from naive GFP transgenic mice were adoptively transferred into lethally irradiated recipients, which were sensitized with 5% OXA on days 1 and 2. On day 5, liver MNCs from recipients or control irradiated mice that did not receive any cells were adoptively transferred into secondary recipients that were challenged 1 month later. (B) DX5 expression on GFP + NK cells in the irradiated recipients that received GFP + DX5 -(top panel) or GFP + DX5 + (bottom panel) NK cells was analyzed on day 5 before transfer. (C) Ear swelling of secondary recipients described in A was measured after OXA challenge (n = 5 per group). ***P < 0.001, ANOVA. Means ± SEM are shown. Hepatocytes (D) or F4/80 + Kupffer cells (E) in the liver of sensitized (blue) or control (gray shaded) WT mice were respectively isolated by a 2-step collagenase perfusion method, then gated and analyzed for FITC expression; the statistical results show FITC MFI on sensitized (n = 6) or control (n = 2) hepatocytes. *P < 0.05, unpaired Student's t test. Means ± SEM are shown. CHS responses. To examine this hypothesis, we sensitized naive WT mice with the hapten FITC and found that FITC fluorescence on hepatocytes of sensitized mice was detected as opposed to normal autofluorescence of hepatocytes ( Figure 2D ), implying that hepatocytes may absorb haptens after sensitization and consistent with the liver as a possible site for hapten sensitization. However, Kupffer cells, the resident macrophages in the liver, seemed less likely to be involved in this process, as FITC + expression was only very rarely detectable in the Kupffer cell population ( Figure 2E ). Accordingly, FITC-laden cells infiltrated the liver, but there were no FITC + cells in the spleen in FITC-sensitized Rag1 -/-mice ( Figure 2F ). Phenotypic assessment of these liver FITC + cells revealed that they were NK1.1 lo Ly6G lo cells, with some cells expressing CD11c and CD11b. Further analysis showed that double-positive CD11b + CD11c + cells existed among FITC + cells, suggestive of the involvement of dendritic cells in NK cell priming. Also, CD11b + F4/80 + Gr-1 + cells with monocyte phenotypes were observed, indicating that circulating macrophages may also function as APCs. Thus, the retention of circulating cells with antigen-presenting ability in the liver makes it possible that DX5 -NK cells are directly primed in the liver.
Preferential trafficking of DX5 -NK cells to the liver without further differentiation. In our initial studies to investigate whether DX5 -NK cells selectively reside in the liver, we adoptively transferred unseparated liver MNCs from CD45.1 + mice into sublethally irradiated CD45.2 + recipients via intravenous injection. One day after transfer, we found that donor-derived DX5 -NK cells accumulated only in the liver, whereas donor-derived DX5 + NK cells showed distribution to other sites ( Figure 3A) , suggestive of distinct migratory tendencies between these 2 subsets. However, it is possible that this result is due to rapid conversion from DX5 -to DX5 + NK cells in various tissues except the liver, and that there is no intrinsic difference between them in migratory capacity. To further determine whether they differ in tissue migration, we adoptively transferred sorted DX5 -and DX5 + liver NK cells and analyzed recipient mice; we consistently found that donor-derived DX5 -NK cells were only detected in the host liver, whereas donor-derived DX5 + NK cells were found in both the host liver and spleen ( Figure 3B ). To further confirm the preferential migration of DX5 -NK cells to the liver, we used another marker of donor NK cells on the purified DX5 -or DX5 + liver NK cells, i.e., the stable expression of GFP, and a different route of transfer. Following adoptive transfer into sublethally irradiated recipients via intraperitoneal injection, donor GFP + DX5 -NK cells were only found in the liver (Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/JCI66381DS1). Moreover, transferred DX5 -NK cells remained DX5 -in recipient liver ( Figure 3B ), suggesting that hepatic DX5 -NK cells are phenotypically stable and do not differentiate into DX5 + NK cells in the steady state. Thus, compared with nondiscriminatory migration of the DX5 + subset to different tissues, hepatic DX5 -NK cells preferentially traffic to the liver and have a low capacity to repopulate other tissues after transfer.
The transcriptional, phenotypic, and functional features of hepatic DX5 -NK cells. We next sought to determine other differences between DX5 -and DX5 + NK cells in transcriptional signature, phenotype, and functional capacity. DX5 -NK1.1 + and DX5 + NK1.1 + liver NK cells were respectively sorted for gene expression microarray analysis (GEO accession number GSE43339). With nearly 22,000 genes tested, 11,122 expressed genes showed no change in DX5 -versus DX5 + NK cells, while 1,507 expressed genes showed a fold change of 2 or greater, among which 566 genes were overexpressed in DX5 -NK cells ( Figure 4A ). The differentially expressed genes included those encoding inhibitory and activating receptors, cytokines, chemokines, adhesion molecules, cytokine receptors, cytotoxic effectors, and transcription factors ( Figure 4B ). We confirmed several of these findings by flow cytometry (Supplemental Table 1 ). Molecules asso- ciated with adhesion, such as CD49a and CD51, and chemokine receptors, CXCR3 and CXCR6, were upregulated on DX5 -NK cells at both transcript and protein levels. We consistently found that CD69 was expressed at higher levels on DX5 -NK cells, but not on S1PR1, which is regulated by CD69 (24) . Some adhesion molecules, such as CD62L (Sell), CD11b (Itgam), CD29 (Itgb1), and CCR9 (Ccr9), were significantly downregulated on DX5 -NK cells. In addition, we observed that Il21r, Rora, and Ahr, which are related to IL-17 production and Th-17 cell development (25) , were also relatively higher in DX5 -NK cells. Eomes, which is implicated in inducing IFN-γ production (26) and NK cell maturation (22) , was expressed at much higher levels in DX5 + NK cells. These differentially expressed transcription factors may reflect the distinct patterns of cytokines released by those 2 NK cell subsets. Genes encoding LAG-3, Helios, and Egr-2, which are preferentially expressed by Treg cells (27) (28) (29) , were also found to be overexpressed by DX5 -NK cells, raising the possibility that DX5 -NK cells may exert negative regulatory actions within the liver. Interestingly, Cd3g, which has been previously reported to be expressed in fetal NK cells (30) was highly expressed in DX5 -NK cells, supporting the possibility of common origins between NK and T cells. In brief, we found that genes associated with immune tolerance, negative regulation, and activation were enhanced in DX5 -NK cells, while DX5 + NK cells were relatively enriched in genes associated with migration, immune response, proliferation, and cell maturation ( Figure 4C and Supplemental Table 2 ). Regarding function, effector molecules such as TRAIL (Tnfsf10), granzyme c (Gzmc), and granzyme f (Gzmf) were overexpressed in DX5 -NK cells, implying that DX5 -NK cells are functional. However, stimulation assays showed that DX5 -NK cells expressed markedly lower levels of CD107a, a degranulation marker of cytotoxic NK cells, and produced slightly lower levels of IFN-γ than DX5 + NK cells after activation (Figure 4 , D and E). These data suggest that the 2 NK cell subsets are functionally different. Further analysis revealed that DX5 + NK cells of the liver phenotypically resembled those of the spleen (Supplemental Figure 2) . Hence, previous findings that bulk liver NK cells are phenotypically different from NK cells in other organs (6, 11, 31) may be due to the unique DX5 -subset of NK cells in the liver.
As the primary site for NK cell development (4, 5) , the BM also contains a very small subpopulation of DX5 -NK cells which were considered to be immature NK cells (6, 7) . Indeed, the low expression of Ly49 receptors and the high expression of NKG2A on liver DX5 -NK cells are consistent with a phenotypically immature population (6, 31) . However, TRAIL was not expressed on BM DX5 -NK cells, in contrast to highly expressed TRAIL on hepatic DX5 -NK cells (ref. 11 and Supplemental Figure 3) . Meanwhile, hepatic DX5 -NK cells expressed much higher CD11c than did BM DX5 -NK cells, indicating that hepatic DX5 -NK cells are phenotypically different from those of the BM that are considered to be immature NK cells (7) . Taken together, the results indicate that hepatic DX5 -NK cells are distinct from DX5 + NK cells and DX5 -NK cells at other sites in transcriptional, phenotypic, and functional aspects.
CD49a + DX5 -NK cells are liver resident. DX5 is widely used to define NK cells in mouse strains that are NK1.1 - (12) , and identification of DX5 -would not be useful as a marker of hepatic NK cell subsets in such strains, indicating that a "positive marker" to define liver NK cell subsets is necessary. By transcriptome analysis, we found that Cd49a, also known as Itga1, was the most highly expressed gene (20-fold higher) among the top 20 most upregulated genes in DX5 -NK cells (Supplemental Figure 4) . Selective expression was further verified by flow cytometry, showing that CD49a was constitutively and highly expressed by hepatic DX5 -NK cells, but not by hepatic DX5 + NK cells or NK cells from other tissues ( Figure  5A ). In addition, NKp46, a pan-NK cell marker (32) , was expressed at high levels on both DX5 -and DX5 + NK cells. Though CD51 was expressed by the majority of DX5 -NK cells, a proportion of DX5 + NK cells were also CD51 + regardless of tissue origin. The expression of CD27 and Thy1.2 on NK cells has been reported to be associated with immune memory by hepatic NK cells (16, 20, 33) , but their expression was detected on NK cells from each examined tissue. CXCR6 was found to be required for NK cell-mediated CHS responses (17) , but NK cells from other organs besides liver also expressed CXCR6, and a fraction of hepatic DX5 -NK cells did not express CXCR6 (Figure 5A ), suggesting that it is not an exclusive marker of liver NK cells. After adoptive transfer, hepatic DX5 -NK cells maintained stable expression of CD49a in recipients, while hepatic DX5 + NK cells were still CD49a -( Figure 5B ). Furthermore, hepatic CD49a + NK cells were identified in BAL-B/c and Rag1 -/-mice as well as in B6 mice ( Figure 5C ), and they were selectively accompanied by high expression of TRAIL, CD51, CXCR3, LAG3, CD44, and CD2 (Supplemental Figure 5) , similar to what was observed in B6 mice (Supplemental Table 1 ). Thus, these results strongly suggest that CD49a + DX5 -NK cells represent an NK cell subset that preferentially resides in the liver.
Importantly, we observed that the CD49a + DX5 -NK cells resided neither in afferent (arterial or portal venous) nor in efferent (postcaval venous) blood of the liver as opposed to CD49a -DX5 + NK cells ( Figure 5D ). Instead, CD49a + DX5 -NK cells were present in the liver sinusoidal blood. Immunofluorescence and immunohistochemistry further confirmed the localization of CD49a + NK cells in the liver sinusoids, albeit somewhat rare on tissue sections ( Figure 5, E and F) . Moreover, CD49a + DX5 -NK cells were seldom present in the spleen, BM, lung, and lymph nodes ( Figure 5A and data not shown).
Furthermore, we studied unmanipulated CD49a + DX5 -and CD49a -DX5 + NK cells in unirradiated CD45 congenic mice that were surgically joined by parabiosis. At the time when substantial chimerism of splenic leukocytes (Supplemental Figure 6 ) was taking place, the CD49a -DX5 + NK cells from each parabiont were found in the spleens and livers of both parabionts ( Figure 6 , A and B). However, CD49a + DX5 -NK cells expressing CD45.1 + were essentially confined to the CD45.1 + livers which contained few, if any, CD49a + DX5 -NK cells from the CD45.2 + parabiont, and vice versa. Taken together with the samplings of the liver afferent, efferent, and sinusoidal vasculature, the preferential migration of transferred, purified hepatic DX5 -NK cells to the liver ( Figure 3B ) and the phenotypic similarities of the DX5 + NK cells in the liver and spleen (Supplemental Figure 2) indicate that CD49a + DX5 -NK cells stably reside in the liver sinusoidal space, whereas CD49a -DX5 + NK cells are circulating NK cells passing through the liver under noninflammatory homeostatic conditions. CD49a + NK cells confer hapten-specific CHS responses. The exclusive and constitutive expression of CD49a by hepatic DX5 -NK cells in the steady state prompted us to examine the function of sensitized CD49a + NK cells in CHS. The recipients of sensitized hepatic CD49a + NK cells displayed vigorous CHS responses after challenge, whereas recipients of the CD49a -subset failed to respond ( Figure 7A) . Moreover, the magnitude of ear swelling showed a nonstatistically significant positive trend for the number of trans-ferred hepatic CD49a + NK cells ( Figure 7B ). To confirm that the recall responses conferred by hepatic CD49a + NK cells were hapten specific, we adoptively transferred hepatic CD49a + NK cells from OXA-or FITC-primed mice into WT recipients. Only when challenged with the sensitizing hapten were the recipients able to mount hapten-specific CHS responses; otherwise, the recipients were unresponsive (Figure 7, C and D) . These data indicate that the hepatic CD49a + NK cells confer hapten-specific CHS responses.
During the memory phase, however, we found that CD49a -DX5 + NK cells dramatically increased in the liver and were predominant at the ears after challenge (data not shown). Surprisingly, CD49a + DX5 -NK cells were still absent in the blood, and NK cells at the site of ear swelling after challenge were predominantly CD49a -DX5 + by flow cytometric analysis (Supplemental Figure 7 and data not shown), which raise the possibility that liver-resident CD49a + DX5 -NK cells may change their phenotype into CD49a -DX5 + NK cells upon exiting the liver, or at the site of inflammation, or they may alternatively cooperate with other cells in the effector phase of CHS.
Liver-resident HPCs differentiate into CD49a + DX5 -NK cells. Since NK cells are commonly considered to be derived from BM hematopoietic stem cells (BM HSCs) throughout adult life, syngeneic BM transplantation (syn-BMT) was performed to investigate the developmental pathway of hepatic DX5 -NK cells. In contrast to the enrichment of DX5 -NK cells in the livers (nearly 50%) of normal mice, very few DX5 -NK cells (less than 15%) were found in the livers of syn-BM transplanted mice even 3 months after BMT (Figure 8A ), suggesting that DX5 -NK cells are not predominantly derived from BM. We then transplanted liver MNCs into lethally irradiated mice, and surprisingly, liver MNCs as well as BM HSCs, supported the survival of irradiated mice ( Figure  8B) , suggestive of the existence of HSCs in the liver. To further address whether the liver contains precursors for this unique NK subset, we adoptively transferred a mixture of BM cells containing heterozygous CD45.1 + CD45.2 + double-positive (DP) BM cells and homozygous CD45.1 + single-positive (SP) liver MNCs at a 1:1 ratio into lethally irradiated homozygous CD45.2 + mice ( Figure  8C ). DP and SP cells in recipients were analyzed 1 month after BMT. Interestingly, liver MNC-derived SP cells were preferentially found in the liver rather than in other organs, but BM-derived DP NK cells were found mainly in the non-liver organs (Supplemental Figure 8 ). In contrast to the predominance of the DX5 + subset among DP NK cells differentiated from BM-HSCs, SP NK cells derived from liver MNCs were primarily DX5 - (Figure 8D ), further suggesting that the HPCs in hepatic liver MNCs are critical for the generation of hepatic DX5 -NK cells. In order to exclude the influence of homeostatic proliferation by donor NK cells, we also transferred purified hepatic CD45.1 + non-T, non-B, non-NK precursors (CD3 -CD19 -NK1.1 -cells) together with supporting Nfil3 -/-BM cells (e.g., NK cell-deficient BM) to lethally irradiated recipients. CD49a + DX5 -NK cells were generated in the recipient liver 1 month after transfer ( Figure 8E ), demonstrating that there are unique direct precursors of the hepatic DX5 -NK cell subset in the liver, and that the hepatic microenvironment supports their further development. Moreover, the presence of CD49a -DX5 + NK cells originating from donor hepatic precursors in the liver of recipients indicates that the liver also contains HPCs for conventional NK cell development. Thus, these results suggest that the liver harbors NK1.1 -CD3 -CD19 -HPCs, which are capable of generating liver-resident CD49a + DX5 -NK cells, whereas BM cells are deficient in giving rise to this NK subset.
Discussion
In this study, we identified a unique NK cell subset residing essentially only in the liver sinusoids, characterized by the CD49a + DX5 -phenotype and endowed with memory capacity. Previous findings that "memory" NK cells were restricted to the liver (16, 17) have generated much interest but have been somewhat puzzling regarding their phenotype. Experiments of cell depletion by various antibodies (16) and adoptive transfer with different NK cell subsets (17, 20, 33) had identified markers potentially associated with memory, such as Thy1.2, Ly49C/I, CXCR6, and CD27, but they were also expressed by splenic NK cells, which did not confer memory. Our finding of the exclusive presence of CD49a + DX5 -NK cells in the liver with memory capacity adds strong support to the concept that only hepatic NK cells, but not splenic NK cells, confer CHS responses.
Although we found other molecules that tended to be expressed on hepatic DX5 -NK cells, such as TRAIL, we provide evidence that CD49a could be used as a preferred marker of liver-resident NK cells. This is likely to be the case in other mouse strains, such as BALB/c mice, because CD49a is not known to be a polymorphic molecule, unlike NK1.1. CD49a associates with the integrin β1 subunit (CD29) to form the CD49a/CD29 (VLA-1) heterodimer, a major receptor for type IV collagen. Previous reports indicate that constitutive VLA-1 expression is largely restricted to mesenchymal cells, including smooth muscle cells, stellate cells, and hepatocytes (34) (35) (36) . In the immune system, resting leukocytes seldom express VLA-1 (37) , with the exception of the liver-resident NK cells described here. More recently published studies, however, found that viral infection induced T cells to express VLA-1, which was required for retention and survival of antigen-specific memory T cells in extralymphatic tissues (38, 39) . In addition, CD49a expression was upregulated in both memory NK cells and memory CD8 + T cells in the MCMV infection model (40) , suggesting that CD49a may be a common marker for memory lymphocytes. Future studies to dissect the role of CD49a in hepatic NK cell function will therefore require NK cell-specific deletion of CD49a.
In the BM, DX5 -NK cells are usually considered to be immature NK cells, since they express intermediate levels of many surface markers compared with NKP and DX5 + NK cells (7) . Moreover, DX5 -NK cells transferred to sublethally irradiated NK1.1 -mice (11) or immunodeficient Il2rg -/-Rag2 -/-mice (22) can generate DX5 + NK cells. In contrast, our data presented here show that hepatic DX5 -NK cells remain CD49a + DX5 -upon transfer to sublethally irradiated syngeneic mice. These results further indicate that DX5 alone cannot be used to discriminate immature BM NK cells from liver NK cells, and the liver CD49a + DX5 -NK cells are stable under steady-state circumstances.
Of note, compared with the CD49a + DX5 -subset selectively located in the liver, CD49a -DX5 + NK cells are the predominant NK cell population in the peripheral organs, and they are phenotypically similar regardless of organ isolation, suggesting that they populate different organs through the systemic circulation. By contrast, we did not find CD49a + DX5 -NK cells in the afferent or efferent blood of the liver. Moreover, we found that the CD49a + DX5 -NK cells reside in the sinusoidal blood of the liver. In addition, our data show that, after adoptive transfer, CD49a + DX5 -NK cells preferentially accumulated in the liver and did not migrate to the spleen, whereas there was no tissue specificity for DX5 + NK cells. Finally, our parabiosis experiments indicate that the unmanipulated CD49a + DX5 -NK cells are generally confined to the liver and do not freely circulate, unlike the CD49a -DX5 + NK cells that are found in the liver due to their propensity to circulate freely. These findings indicate that under steady-state conditions, CD49a + DX5 -NK cells are the resident NK cell population of the liver, whereas CD49a -DX5 + NK cells are a migratory subset, raising the possibility that other tissues may have organ-specific NK cell subsets that may be diluted by migratory CD49a -DX5 + NK cells.
Figure 6
Minimal exchange of liver CD49a + DX5 -NK cells in parabiotic mice. WT B6 (CD45.2) mice were parabiosed to congenic B6-CD45.1 mice. At day 14 postsurgery, the spleen and liver were harvested and flow cytometry was performed. (A) Representative dot plot of the liver and spleen gated on live CD3 -NK1. the lymph node (15) . Inasmuch as CD49a + DX5 -NK cells are liver resident, it is possible that NK cell "priming" occurs in the liver. Consistent with this hypothesis, it should be noted that there are very few NK cells in lymph nodes where we found essentially no CD49a + DX5 -NK cells and where we found that haptens, such as FITC, readily traffic to the liver where they are associated with cells having phenotypes typically displaying APC function. While our data do not exclude that sensitization may result in the recruitment of CD49a + DX5 -NK cells to the draining lymph node, sensitized liver CD49a + DX5 -NK cells ultimately play a role in "memory" NK cell responses.
Interestingly, we found few CD49a + DX5 -NK cells at the cutaneous site of hapten challenge. This surprising finding is likely related to recent studies indicating differences in the histology of T cell-versus NK cell-mediated CHS reactions, suggesting that their effector mechanisms differ (18) . Moreover, this study failed to find NK cells at the CHS site, which contrasts with our finding that CD49a -DX5 + NK cells were at the CHS lesion, more in line with other studies that described NK cells in the lesions (16) . Our findings may be due to further differentiation of the liver-resident CD49a + DX5 -subset, with a loss of CD49a expression after exiting the liver, or to other cells that are involved in the effector phase of "memory" NK cell responses. Regardless, while these postulated effects require further investigation, identification of a unique subset of hepatic NK cells provides a new framework for the understanding of NK cell "memory."
Methods
Mice. B6 and BALB/c mice were purchased from the Shanghai Experimental Animal Center (Shanghai, China). Rag1 -/-(B6) and GFP transgenic (B6) mice were obtained from the Model Animal Research Center (Nanjing, China), which obtained the mice from The Jackson Laboratory. CD45.1 + , B6.SJL, and Cxcr6 -/-(Cxcr6 alleles replaced with cDNA encoding GFP; B6 background) mice (44) were purchased from the Jackson Laboratory. Cxcr6 +/-mice were generated and bred in house. Nfil3 +/-(B6) mice were provided by Tak W. Mak (University of Toronto, Toronto, Ontario, Canada). Cxcr6 +/-, CD45.1 + CD45.2 + , and Nfil3 -/-mice were bred in house. We maintained mice in a specific pathogen-free facility for use according to the guidelines for experimental animals at the University of Science and Technology of China and Washington University.
Antibody staining and flow cytometry. We purchased FITC-anti-Ly49C/I/ F/H, FITC-anti-CD94, PE-anti-CD29, PE-anti-TRAIL, PerCP CY5.5-anti-CCR7, and purified anti-CX3CR1 from eBioscience, and PE-anti-CCR6 from R&D Systems. All other antibodies for flow cytometry were purchased from BD Biosciences. Prior to staining with antibodies, cells were The liver has long been known to harbor large numbers of NK cells, and previous studies have suggested that liver NK cells are somewhat different from conventional NK cells (6, 11, 22, 41) . However, definitive features that distinguish liver and conventional NK cells were not identified previously. Our studies also suggest that CD49a + DX5 -NK cells may be related to the morphologically identified "pit" cells, which were first demonstrated in rat liver (42) and are now known to be NK cells that reside in the liver sinusoids. The blood flow within liver sinusoids (43) is low, perhaps allowing the CD49a + DX5 -NK cells to be retained in the liver by adhesion molecules and thus not take up residence at other sites.
Although BM is generally considered as the primary organ for NK cell generation and development, our results presented here indicate an alternative developmental pathway for liver-resident NK cells. The low frequency of donor hepatic DX5 -NK cells after BMT suggests that BM is deficient in generating liver-resident NK cells. The survival of lethally irradiated mice receiving liver MNCs and the generation of CD49a + DX5 -NK cells from liver-resident HPCs strongly support the hypothesis that the liver contains the precursors of liver-resident NK cells. Furthermore, liver HPCs are much more effective at giving rise to hepatic DX5 -NK cells than BM cells, implying that liver-resident NK cells originate primarily from the liver rather than from the BM. Indeed, during fetal life, NK cell development occurs in the liver, and CD49a + DX5 -NK cells are predominant (data not shown), leading to the possibility that the "seeds" for CD49a + DX5 -NK cells in the liver emerge very early in life and persist with age.
Yet, these liver-resident CD49a + DX5 -NK cells confer hapten-specific "memory," suggesting that they must somehow become sensitized to haptens placed on the skin, perhaps by haptenated cells that migrate to the liver. Our new findings thus raise this possibly novel scenario that contrasts with traditional views of T cell priming and the current hypothesized scheme of NK cell "priming" in
Figure 7
CD49a + NK cells have the capacity to confer hapten-specific CHS responses. (A) Naive B6 mice received 8 × 10 4 CD49a + or CD49a -liver NK cells from OXA-sensitized WT mice and were challenged 1 month later (n = 4 per group). (B) Naive B6 mice received the indicated number of CD49a + liver NK cells from OXA-sensitized WT mice and were challenged 1 month later (n = 3 per group). (C and D) Naive B6 mice received 8 × 10 4 CD49a + or CD49a -liver NK cells from OXA --sensitized (C), or FITC --sensitized (D) WT mice and were challenged with OXA or FITC 1 month later as indicated (n = 4 for the FITC plus OXA group; n = 5 for the other groups). All data are from 1 experiment representative of 2 independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001, unpaired Student's t test (A, C, and D) , or ANOVA (B). Means ± SEM of ear swelling are shown in all panels.
erythrocytes. PBMCs were obtained by lysing erythrocytes of the blood. Lymphocytes of inguinal lymph nodes (iLNs) were obtained by mechanical disruption. Hepatocytes and Kupffer cells were isolated using a 2-step collagenase perfusion method as described previously (46) .
Cell sorting and transfer. A FACSAria cell sorter (BD Biosciences) was used to purify NK cells or different NK cell subsets. Purity of sorted cell populations was more than 95%, as verified by post-sort flow cytometry. For the study of CHS, we used unirradiated or lethally irradiated (12 Gy given 1 day before adoptive transfer) WT B6 mice that received intravenous injection of hepatic NK cell subsets, splenic NK cells, or liver MNCs. To study the trafficking and development of liver NK cells, we sublethally irradiated (6. incubated with rat immunoglobulin for 30 minutes to block Fc receptors. We performed flow cytometry on an LSR II (BD Biosciences), and analyzed data with FlowJo software (Tree Star). To assess IFN-γ production, we treated liver MNCs with recombinant human IL-2 (1,000 U/ml; Kingsley) and murine recombinant IL-12 (10 ng/ml; PeproTech) for 18 hours, and added monensin (10 μg/ml; Sigma-Aldrich) during the last 4 hours. Cells were then collected and stained for surface markers. After fixation and permeabilization, cells were intracellularly stained with PE-anti-IFN-γ. For CD107a analysis, liver MNCs were incubated with YAC-1 cells at a ratio of 1:1 with monensin (10 μg/ml) and PE-anti-CD107a for 4 hours before staining with other antibodies.
Cell preparation. Liver MNCs were isolated essentially as described previously (45) . Briefly, we passed livers through a 200-gauge stainless steel mesh. The cells were resuspended in 40% Percoll (GE Healthcare), then gently overlaid onto 70% Percoll and centrifuged at 1,260 g for 30 minutes. Liver MNCs were collected from the interphase. Splenocytes were isolated by forcing the spleen through stainless steel mesh and subsequently lysing erythrocytes. We obtained BM cells by flushing femurs and then lysing temperature and the sections were rinsed 3 times in PBS. We performed serum blocking by incubating the sections in goat serum for 30 minutes at room temperature. Sections were then incubated in anti-CD49a (BD Biosciences), and anti-NK1.1 (BD Biosciences) or Armenian hamster IgG2 (BD Biosciences) and mouse IgG2a (BD Biosciences) in a 1:100 dilution overnight at 4°C and rinsed 3 times in PBS. For detection of CD49a, the sections were incubated in goat anti-Armenian hamster IgG-HRP (Rockland Immunochemicals) in a 1:1,000 dilution for 30 minutes at 37°C and rinsed 3 times in PBS. Sections were then incubated in a peroxidase substrate solution using DAB (Vector Laboratories) for stable brown staining and rinsed in pure water. For NK1.1 staining, an SP-9002 kit (ZSGB-BIO) was used. Sections were incubated in biotinylated goat anti-mouse IgG for 30 minutes at 37°C and rinsed 3 times in PBS. Then sections were incubated in streptavidin-HRP for 30 minutes at 37°C and rinsed 3 times in PBS. Sections were incubated in a peroxidase substrate solution using DAB (Vector Laboratories) for stable purple staining and rinsed in pure water. Finally, sections were stained in hematoxylin for 5 seconds, rinsed in pure water, dehydrated, cleared, and coverslipped. We examined the stained sections using an Olympus IX-81 microscope. The antibodies mentioned above were dissolved in PBS.
Parabiosis. WT (CD45.2 + ) and CD45.1 + B6 female mice controlled for age and weight were parabiosed for 14 days, following guidelines from the laboratory of Michel Nussenzweig (Rockefeller University, New York, New York, USA) (47) . Prior to surgery, the mice were co-housed, shaved, and weighed. A longitudinal incision was made along the lateral aspect of each mouse. The mice were then joined at the elbow and knee with dissolvable sutures and the incision was closed with wound clips. Postoperative care included the administration of buprenex compound for pain management, 5% dextrose and 0.9% sodium chloride, nutritional gel packs in each cage, and antibiotics (Sulfatrim) in the drinking water for the duration of the experiment. The procedure was approved by the Animal Studies Committee at Washington University.
Statistics. Statistical significance of differences was determined by Student's t tests for 2 groups or ANOVA for 3 groups. P values less than 0.05 were considered significant.
